Henan Lingrui Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Henan Lingrui Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Henan Lingrui Pharmaceutical Co Ltd (600285) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥140.12 Million ≈ $20.50 Million USD) by net assets (CN¥3.28 Billion ≈ $480.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Henan Lingrui Pharmaceutical Co Ltd (1999–2025)

Cash flow conversion efficiency of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. This chart illustrates how Henan Lingrui Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Henan Lingrui Pharmaceutical Co Ltd for real-time trading data and today's change.

Henan Lingrui Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Henan Lingrui Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Henan Lingrui Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Lingrui Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Henan Lingrui Pharmaceutical Co Ltd (600285) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Simplo Technology Co Ltd TWO:6121	0.027x
King’s Town Bank TW:2809	0.025x
Centrus Energy Corp. NYSE MKT:LEU	-0.063x
Domain Holdings Australia Ltd AU:DHG	0.049x
AVI LTD (UNSP.ADR)/5 F:IZ60	N/A
NRW Holdings Ltd AU:NWH	0.261x
Shanghai Xinhua Media Co Ltd SHG:600825	-0.002x
Diebold Nixdorf, Incorporated NYSE:DBD	-0.021x

Annual Cash Flow Conversion Efficiency for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. Review Henan Lingrui Pharmaceutical Co Ltd (600285) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.44 Billion ≈ $502.78 Million	CN¥553.88 Million ≈ $81.05 Million	0.161x	-43.31%
2024-12-31	CN¥3.08 Billion ≈ $450.74 Million	CN¥875.86 Million ≈ $128.17 Million	0.284x	-2.17%
2023-12-31	CN¥2.80 Billion ≈ $409.54 Million	CN¥813.43 Million ≈ $119.03 Million	0.291x	-10.94%
2022-12-31	CN¥2.56 Billion ≈ $374.38 Million	CN¥834.91 Million ≈ $122.17 Million	0.326x	-11.77%
2021-12-31	CN¥2.29 Billion ≈ $334.60 Million	CN¥845.69 Million ≈ $123.75 Million	0.370x	+90.63%
2020-12-31	CN¥2.32 Billion ≈ $339.80 Million	CN¥450.53 Million ≈ $65.93 Million	0.194x	-4.30%
2019-12-31	CN¥2.22 Billion ≈ $324.92 Million	CN¥450.15 Million ≈ $65.87 Million	0.203x	-2.67%
2018-12-31	CN¥2.09 Billion ≈ $306.49 Million	CN¥436.25 Million ≈ $63.84 Million	0.208x	+333.20%
2017-12-31	CN¥2.20 Billion ≈ $322.52 Million	CN¥105.97 Million ≈ $15.51 Million	0.048x	+60.53%
2016-12-31	CN¥2.11 Billion ≈ $309.08 Million	CN¥63.26 Million ≈ $9.26 Million	0.030x	-67.07%
2015-12-31	CN¥1.72 Billion ≈ $252.28 Million	CN¥156.82 Million ≈ $22.95 Million	0.091x	+14.19%
2014-12-31	CN¥1.56 Billion ≈ $228.39 Million	CN¥124.32 Million ≈ $18.19 Million	0.080x	-38.36%
2013-12-31	CN¥984.89 Million ≈ $144.12 Million	CN¥127.27 Million ≈ $18.62 Million	0.129x	+483.53%
2012-12-31	CN¥696.97 Million ≈ $101.99 Million	CN¥15.43 Million ≈ $2.26 Million	0.022x	-62.59%
2011-12-31	CN¥684.01 Million ≈ $100.09 Million	CN¥40.49 Million ≈ $5.92 Million	0.059x	+1163.14%
2010-12-31	CN¥709.69 Million ≈ $103.85 Million	CN¥-3.95 Million ≈ $-578.20K	-0.006x	-102.71%
2009-12-31	CN¥645.69 Million ≈ $94.48 Million	CN¥132.61 Million ≈ $19.40 Million	0.205x	+158.23%
2008-12-31	CN¥549.72 Million ≈ $80.44 Million	CN¥43.72 Million ≈ $6.40 Million	0.080x	+188.20%
2007-12-31	CN¥579.24 Million ≈ $84.76 Million	CN¥15.99 Million ≈ $2.34 Million	0.028x	-49.82%
2006-12-31	CN¥486.67 Million ≈ $71.21 Million	CN¥26.76 Million ≈ $3.92 Million	0.055x	-21.07%
2005-12-31	CN¥479.80 Million ≈ $70.21 Million	CN¥33.43 Million ≈ $4.89 Million	0.070x	-7.89%
2004-12-31	CN¥469.45 Million ≈ $68.70 Million	CN¥35.51 Million ≈ $5.20 Million	0.076x	+43.63%
2003-12-31	CN¥451.69 Million ≈ $66.10 Million	CN¥23.79 Million ≈ $3.48 Million	0.053x	-68.38%
2002-12-31	CN¥416.74 Million ≈ $60.98 Million	CN¥69.41 Million ≈ $10.16 Million	0.167x	+1861.90%
2001-12-31	CN¥401.79 Million ≈ $58.79 Million	CN¥3.41 Million ≈ $499.14K	0.008x	-5.34%
2000-12-31	CN¥408.46 Million ≈ $59.77 Million	CN¥3.66 Million ≈ $536.06K	0.009x	-88.42%
1999-12-31	CN¥62.08 Million ≈ $9.08 Million	CN¥4.81 Million ≈ $703.65K	0.077x	--

About Henan Lingrui Pharmaceutical Co Ltd

SHG:600285 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.98 Billion

CN¥13.54 Billion CNY

Market Cap Rank

#5979 Global

#1114 in China

Share Price

CN¥23.87

Change (1 day)

+1.27%

52-Week Range

CN¥18.64 - CN¥23.87

All Time High

CN¥26.75